GlassScriptPhysician profile
Anita Kedia
NPI 1538182613
$8,675.51
in general payments reported to CMS, 2019-2025
31 companies · $444 in 2025
The $444 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,638 · 2020: $835 · 2021: $1,605 · 2022: $1,175 · 2023: $1,060 · 2024: $1,918 · 2025: $444.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,422.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,441.72 | 2019-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $1,128.14 | 2019-2025 | |
| Abbott Laboratories | $568.29 | 2019-2024 | Mitraclip |
| Boston Scientific Corporation | $543.42 | 2021-2024 | Watchman Access System, Rotapro, Wolverine Coronary Cutting Balloon |
| Amgen INC. | $507.29 | 2019-2025 | Repatha |
| Shockwave Medical, INC | $494.73 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Pfizer INC. | $426.53 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $391.54 | 2019-2024 | Jardiance |
| Esperion Therapeutics, INC. | $329.80 | 2020-2021 | |
| Amarin Pharma, INC. | $315.96 | 2019-2021 | |
| Actelion Pharmaceuticals US, INC. | $315.41 | 2019-2025 | Opsumit, Uptravi |
| Merck Sharp & Dohme LLC | $301.80 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $263.62 | 2019-2024 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $260.67 | 2023-2024 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $169.54 | 2019-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $167.17 | 2023-2024 | Inpefa |
| Regeneron Healthcare Solutions, INC. | $151.71 | 2019 | |
| Edwards Lifesciences Corporation | $134.69 | 2024 | Sapien 3 Ultra Resilia |
| Bayer Healthcare Pharmaceuticals INC. | $132.01 | 2021-2022 | |
| Abiomed | $126.07 | 2023-2024 | Impella |
| Biotronik INC. | $119.55 | 2024-2025 | Biomonitor, Acticor 7 Vr-T Dx, Amvia Edge |
| Kowa Pharmaceuticals America, INC. | $91.70 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $50.01 | 2019-2020 | |
| Irhythm Technologies, INC. | $44.95 | 2023-2024 | Zio Xt Patch |
| Philips North America LLC | $43.66 | 2024 | (Cm9) Amb Mon & Diag Und |
| Akcea Therapeutics, INC. | $41.88 | 2019-2020 | |
| Medtronic, INC. | $26.50 | 2024 | Mycarelink |
| Alnylam Pharmaceuticals INC. | $24.92 | 2024 | Onpattro |
| Heartflow, INC. | $21.93 | 2024 | |
| Abbvie INC. | $21.78 | 2024 | |
| United Therapeutics Corporation | $18.52 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anita Kedia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.